Mast cell cultures: Bench to bedside

Clinical and Experimental Allergy

Volumn 28, Issue 10, 1998, Pages 1182-1190

  Rossi, G L ^a   Di Comite, V ^a   Olivieri, D ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD40 ANTIGEN; DEXAMETHASONE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG RESEARCH; DRUG TARGETING; HUMAN; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTHMA; CELLS, CULTURED; FIBROSIS; HUMANS; HYPERSENSITIVITY; MAST CELLS; MOLECULAR BIOLOGY; RESEARCH; SPECIES SPECIFICITY;

EID: 0032467352     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00376.x     Document Type: Review

References (79)

1. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997; 99:155-60.
2. Warner JA, Kroegel C. Pulmonary immune cells in health and disease: mast cells and basophils. Eur Respir J 1994; 7:1326-41.
3. Rossi GL, Olivieri D. Does the mast cell still have a key role in asthma? Chest 1997; 112:523-9.
4. Plaut M, Pierce JH, Watson CJ et al. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or calcium ionophore. Nature 1989; 339:64-7.
5. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989; 339:150-2.
6. Burd PR, Rogers HW, Gordon JR et al. Interleukin 3- dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 179:245-57.
7. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cells as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
8. Enerback L. The differentiation and maturation of inflammatory cells involved in the allergic response: mast cells and basophils. Allergy 1997; 52:4-10.
9. Enerback L. Mast cell heterogeneity: the evolution of the concept of a specific mucosal mast cell. In: Befus AD, Bienenstock J, Denburg JA eds. Mast cell differentiation and Heterogeneity. New York: Raven Press 1986:1-26.
10. Bienenstock J, Befus AD, Denburg JA. Mast cell heterogeneity: Basic questions and clinical implications. In: Befus AD, Bienenstock J, Denburg JA eds. Mast cell differentiation and Heterogeneity. New York: Raven Press 1986:391-402.
11. Church MK, Okayama Y, Bradding P. Functional mast cell heterogeneity. In: Busse WW, Holgate ST eds. Asthma and rhinitis. Boston: Blackwell Scientific 1995:209-20.
12. Galli SJ. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol 1997; 113:14-22.
13. Nakano T, Sonoda T, Hayashi C et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cell. J Exp Med 1985; 162:1025-43.
14. Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for c-kit receptor. Int Arch Allergy Immunol 1995; 107:51-3.
15. Mekori YA, Metcalfe DD. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol 1994; 153:2194-203.
16. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood 1997; 89:2654-63.
17. Durand B, Migliaccio G, Yee NS et al. Long term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood 1994; 84:3667-74.
18. Valent P, Spanblochl E, Sperr WR et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in a long term culture. Blood 1992; 80:2237.
19. Kirshenbaum AS, Kessler SW, Goff JP et al. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992; 148:772.
20. Irani AM, Nilsson G, Miettinen U et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80:3009.
21. Dvorak AM, Furitsu T, Kissell-Rainville S., Ishizaka T. Ultrastructural identification of human mast cells resembling skin mast cells stimulated to develop in long term human cord blood mononuclear cells cultured with 3T3 murine skin fibroblasts. J Leukoc Biol 1992; 51:557-69.
22. 2 from cord blood mononuclear cells. J Immunol 1996; 157:343-50.
23. Valent P, Besemer J, Sillaber CH et al. Failure to detect IL-3 binding sites on human mast cells. J Immunol 1990; 145:3432-7.
24. Metcalfe DD. Hematopoietic regulators: redundancy or subtlety? Blood 1993; 82:3515-23.
25. Yanagida M, Fukamaki H, Ohgami K et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995; 86 (10):3705-14.
26. Valent P, Schmidt G, Besemer J et al. Interleukin-3 is a differentiation factor for human basophils. Blood 1989; 73:1763-9.
27. Valent P, Besemer J, Muhm M et al. Interleukin-3 activate human basophils via high affinity binding site. Proc Natl Acad Sci USA 1989; 86:5542-6.
28. Kirshenbaum AS, Goff JP, Dreskin SC et al. IL-3 dependent growth of basophil-like and mast-like cells from human bone marrow. J Immunol 1989; 142:2424-9.
29. Tashiro M, Kawakami Y, Abe R et al. Increased secretions of TNF-α by costimulation of mast cells via CD28 and FceRI. J Immunol 1997; 158:2382-9.
30. 2 [IPQ] mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J Immunol 1997; 158:2350-5.
31. Katz HR, Austen KF. A newly recognized pathway for the negative regulation of mast cell-dependent hypersensivity and inflammation mediated by an endogenous cell surface receptor of the gp49 family. J Immunol 1997; 158:5065-70.
32. Rossi GL, Yen A, Barrett KE. IgE and adenosine 5′ triphosphate receptors on immature murine mast cells are functionally linked to signal transduction mechanisms. J Allergy Clin Immunol 1992; 90 (5):765-71.
33. Bradding P. Human mast cells cytokines. Clin Exp Allergy 1996; 26:13-9.
34. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophils and basophil recruitment. J Allergy Clin Immunol 1994; 94:427-38.
35. Kawabori S, Kanai N, Tosho T, Adachi T. Existence of c-kit receptor-positive, tryptase negative, IgE-negative cells in human allergic nasal mucosa: a candidate for mast cell progenitor. Int Arch Allergy Immunol 1997; 112:36-43.
36. Shimizu Y, Irani AA, Brown EJ, Ashman LK, Schwartz LB. Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51/CD61 (αvβ3) integrin. Blood 1995; 86:930-9.
37. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemiotactic factor for human mast cells. J Immunol 1994; 153:3717.
38. Nilsson G, Johnell M, Hammer CH et al. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996; 157:1693-8.
39. Dastych J, Hardison MC, Metcalfe DD. Aggregation of low affinity IgG receptors induces mast cell adherence to fibronectin, J Immunol 1997; 158:1803-09.
40. Ogasawara T, Murakami M, Suzuki-Nishimura T, Uchida MK, Kudo I. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and citokine expression in response to G-protein activating polybasic compounds after cocoltures with fibroblasts in the presence of c-kit ligand. J Immunol 1997; 158:393-404.
41. Bressler RB, Lesko J, Jones ML et al. Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high affinity IgE receptor ligation. J Allergy Clin Immunol 1997; 99:508-14.
42. Frandji P, Oskeritzian C, Cacaraci F et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class 11-restricted T cells hybridoma. J Immunol 1993; 151:6318-28.
43. Frandji P, Tkaczyk C, Oskeritzian C et al. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 1996; 26:2517-28.
44. Tkaczyk C, Frandji P, Botros HG et al. Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities. J Immunol 1996; 157:1720-8.
45. Gauchat JF, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365 (6444):340-3.
46. Pawankar R, Okuda M, Yssel H, Okomura K, Ra C. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the FceRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997; 99 (7): 1492-9.
47. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381:75-7.
48. Levi-Schaffer F, Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy 1997; 27:64-70.
49. Dvorak AM, Kissell S. Granule changing of human skin mast cells characteristics of piecemeal degranulation and associated with recovery during wound healing in situ. J Leukoc Biol 1991; 49:147-210.
50. Dvorak AM, Morgan ES. Diamine oxidase-gold enzyme affinity ultrastructural demonstration that human gut mucosal mast cells secrete histamine by piecemeal degranulation in vivo. J Allergy Clin Immunol 1997; 99:812-20.
51. Gruber BL, Kew RR, Jelaska A et al. Human mast cells activate fibroblasts. J Immunol 1997; 158:2310-7.
52. Kendall JC, Li XH, Galli SJ, Gordon JR. Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 1997; 99:113-23.
53. Wershil BK. Role of mast cells and basophils in gastrointestinal inflammation. In: Marone G, ed. Human basophil and mast cells: clinical aspects. Chem Immunol Basel, Karger 1995; 62:187-203.
54. Arnason JA, Malone DG. Role of mast cells in arthritis. In Marone G, ed. Human basophil and mast cells: clinical aspects. Chem Immunol Basel, Karger 1995; 62:204-38.
55. Bienenstock J, Blennerhasset M, Kakuta Y et al. Evidence for central and peripheral nervous system interactions with mast cells. In: Galli SJ, Austen KF eds. Mast cells and basophils differentiation and function in health and disease. New York: Raven Press 1989:275-284.
56. Marshall JS, Waserman S. Mast cells and the nerves potential interactions in the context of chronic disease. Clin Exp Allergy 1995; 25:102-10.
57. Patella V, Genovese A, Marone G. What are human heart mast cells for? In: Marone G ed. Human basophil and mast cells: clinical aspects. Chem Immunol Basel, Karger 1995; 62:108-31.
58. Blair RJ, Meng H, Marchese MJ et al. Human mast cell stimulate vascular tube formation. J Clin Invest 1997; 99 (11):2691-700.
59. Harveit F. Mast cells and methacromasia in human breast cancer: their occurrence significance and consequence. A preliminary report. J Pathol 1981; 134:7-11.
60. Crowle PK, Starkley JR. Mast cells and tumour associated angiogenesis. In: Galli SJ, Austen KF, eds. Mast cells and basophils differentiation and function in health and disease. New York: Raven Press 1989:307-17.
61. Roche WR. Mast cells and tumours: the specific enhancement of tumour proliferation in vitro. Am J Pathol 1985; 119:57-64.
62. Austen KF. Systemic mastocytosis. N Engl J Med 1992; 326 (9):639-40.
63. Daeron M, Sterk AR, Hirata F, Ishizaka T. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J Immunol 1982; 129: 1212-8.
64. Marquardt DL. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J Immunol 1983; 131 (2):934-9.
65. Schleimer RP. Effects of glucocorticoids on inflammtory cells relevant to their therapeutic application in asthma. Am Rev Respir Dis 1990; 141: S59-69.
66. Wershil BK, Furota GT, Lavigne JA et al. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. J Immunol 1995; 154: 1391-8.
67. Eklund KK, Humphries DE, Xia Z et al. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-α, and the II.-10 induced expression of chimases. J Immunol 1997; 158:4373-80.
68. Rumsaeng V, Vliagofits H, Oh CK, Metcalf DD. Lymphotactin gene expression in mast cells following Fce receptor I aggregation. J Immunol 1997; 158: 1353-60.
69. Finotto S, Mekori YA, Metcalfe DD. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells. J Clin Invest 1997; 99: 1721-28.
70. Tachimoto H, Iikunt Y, Saito H. Corticosteroids inhibit cytokine production but not histamine release from cultured human mast cells. J Allergy Clin Immunol 1997; 99:S123.
71. Pearce FL. Inhibition by disodium cromoglycate of anaphylactic histamine secretion from rat peritoneal mast cells in the presence of phosphatidil serine. Agents Action 1983; 13:212-5.
72. Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 1982; 128:2481-6.
73. Marquardt DL, Walker LL, Wassermann SI, Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow. Am Rev Respir Dis 1986; 133:1105-9.
74. Di Comite V, Rossi GL, Bertorelli G, Olivieri D. Nedocromil sodium does not affect β-hexosaminidase release in bone marrow derived mast cells after acute or prolonged exposure. Abst. accepted for presentation at World Asthma Meeting, Barcelona, 10-13 December 1998.
75. Okayama Y, Benyon RC, Rees PH, et al. Inhibition profile of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lungs, tonsil, adenoid and intestine. Clin Exp Allergy 1992; 22:401-9.
76. Bissonnette EY, Enciso JA, Befus AD. Inhibition of tumour necrosis factor alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995; 102:78-84.
77. Genovese A, Patella V, De Crescenzo G, et al. Loratidine and desethoxylcarbonyl-loratidine inhibits the immunological release of mediators from human Fc∈RI+ cells. Clin Exp Allergy 1997; 27:559-67.
78. Stellato C, Marone G. Mast cells and basophils in adverse reactions to drugs used during general anaesthesia. In: Marone G, ed. Human basophil and mast cells: clinical aspects. Chem Immunol Basel, Karger 1995; 62:108-31.
79. Devalia JL, Bayram H, Rusznak C et al. Mechanisms of pollution-induced airway disease: in vitro studies in the upper and lower airways. Allergy 1997; 52 (38):45-51.